Cozad Asset Management Inc. Has $1.86 Million Holdings in The Procter & Gamble Company (NYSE:PG)

Cozad Asset Management Inc. decreased its holdings in shares of The Procter & Gamble Company (NYSE:PGFree Report) by 6.3% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 12,709 shares of the company’s stock after selling 858 shares during the quarter. Cozad Asset Management Inc.’s holdings in Procter & Gamble were worth $1,862,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also modified their holdings of PG. Demars Financial Group LLC boosted its holdings in Procter & Gamble by 4.4% in the fourth quarter. Demars Financial Group LLC now owns 1,497 shares of the company’s stock valued at $219,000 after acquiring an additional 63 shares during the last quarter. Emerald Advisors LLC increased its position in shares of Procter & Gamble by 1.8% during the fourth quarter. Emerald Advisors LLC now owns 3,775 shares of the company’s stock worth $553,000 after buying an additional 65 shares during the period. O Brien Wealth Partners LLC raised its stake in Procter & Gamble by 3.3% during the fourth quarter. O Brien Wealth Partners LLC now owns 2,062 shares of the company’s stock worth $302,000 after buying an additional 65 shares during the last quarter. LWM Advisory Services LLC lifted its holdings in Procter & Gamble by 2.1% in the fourth quarter. LWM Advisory Services LLC now owns 3,143 shares of the company’s stock valued at $461,000 after buying an additional 66 shares during the period. Finally, KFA Private Wealth Group LLC boosted its position in Procter & Gamble by 2.2% during the third quarter. KFA Private Wealth Group LLC now owns 3,054 shares of the company’s stock valued at $445,000 after acquiring an additional 67 shares during the last quarter. 65.77% of the stock is owned by institutional investors.

Insider Buying and Selling at Procter & Gamble

In related news, CEO Gary A. Coombe sold 22,000 shares of the firm’s stock in a transaction dated Friday, February 23rd. The shares were sold at an average price of $161.32, for a total transaction of $3,549,040.00. Following the completion of the sale, the chief executive officer now owns 36,845 shares in the company, valued at $5,943,835.40. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. In other news, insider Balaji Purushothaman sold 28,369 shares of the company’s stock in a transaction on Tuesday, April 23rd. The stock was sold at an average price of $161.49, for a total transaction of $4,581,309.81. Following the transaction, the insider now owns 11,507 shares of the company’s stock, valued at approximately $1,858,265.43. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Gary A. Coombe sold 22,000 shares of Procter & Gamble stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $161.32, for a total value of $3,549,040.00. Following the completion of the sale, the chief executive officer now directly owns 36,845 shares of the company’s stock, valued at approximately $5,943,835.40. The disclosure for this sale can be found here. Insiders sold 55,865 shares of company stock worth $9,009,280 in the last quarter. 0.17% of the stock is currently owned by company insiders.

Procter & Gamble Price Performance

PG opened at $163.24 on Wednesday. The firm’s fifty day moving average price is $159.82 and its two-hundred day moving average price is $153.91. The company has a market capitalization of $385.27 billion, a price-to-earnings ratio of 26.67, a P/E/G ratio of 3.28 and a beta of 0.44. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.69 and a quick ratio of 0.48. The Procter & Gamble Company has a 1 year low of $141.45 and a 1 year high of $164.32.

Procter & Gamble (NYSE:PGGet Free Report) last issued its quarterly earnings data on Friday, April 19th. The company reported $1.52 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.42 by $0.10. Procter & Gamble had a net margin of 18.00% and a return on equity of 33.91%. The business had revenue of $20.20 billion during the quarter, compared to the consensus estimate of $20.43 billion. During the same period in the prior year, the firm posted $1.37 EPS. The firm’s quarterly revenue was up .6% compared to the same quarter last year. As a group, analysts anticipate that The Procter & Gamble Company will post 6.55 earnings per share for the current fiscal year.

Procter & Gamble Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, May 15th. Investors of record on Friday, April 19th will be issued a dividend of $1.0065 per share. This is a positive change from Procter & Gamble’s previous quarterly dividend of $0.94. This represents a $4.03 dividend on an annualized basis and a yield of 2.47%. The ex-dividend date of this dividend is Thursday, April 18th. Procter & Gamble’s dividend payout ratio (DPR) is 65.85%.

Wall Street Analyst Weigh In

A number of research analysts have recently issued reports on the company. Deutsche Bank Aktiengesellschaft dropped their price objective on Procter & Gamble from $172.00 to $171.00 and set a “buy” rating on the stock in a research note on Monday, April 22nd. Raymond James raised their price objective on shares of Procter & Gamble from $170.00 to $175.00 and gave the stock an “outperform” rating in a research report on Wednesday, January 24th. Royal Bank of Canada boosted their target price on shares of Procter & Gamble from $156.00 to $157.00 and gave the company a “sector perform” rating in a research report on Wednesday, January 24th. StockNews.com cut shares of Procter & Gamble from a “buy” rating to a “hold” rating in a report on Thursday, February 29th. Finally, Truist Financial upgraded shares of Procter & Gamble from a “hold” rating to a “buy” rating and upped their price objective for the company from $160.00 to $175.00 in a report on Monday, March 11th. Seven investment analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $169.76.

Check Out Our Latest Stock Analysis on Procter & Gamble

Procter & Gamble Profile

(Free Report)

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.

Featured Articles

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.